Stock Events

Haleon 

$4.53
1063
+$0.1+2.32% Today

Statistics

Day High
4.33
Day Low
4.27
52W High
4.38
52W Low
3.81
Volume
2,500
Avg. Volume
17,494
Mkt Cap
40.68B
P/E Ratio
0
Dividend Yield
2.36%
Dividend
0.11

Upcoming

1
AUG
Earnings
14
SEP
Dividend Ex
16
NOV
Dividend Payment
14
MAR 25
Dividend Ex
16
MAY 25
Dividend Payment
14
SEP 25
Dividend Ex
16
NOV 25
Dividend Payment
14
MAR 26
Dividend Ex
16
MAY 26
Dividend Payment
14
SEP 26
Dividend Ex

Dividends

2.36%Dividend Yield
May 24
$0.05
Oct 23
$0.02
Apr 23
$0.03
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
106.96%

Earnings

1AugConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Next
0
10.32
20.65
30.97
Expected EPS
8.84438939427
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HLNCF. It's not an investment recommendation.
Alphabet
68918
GOOGL
Apple
60554
AAPL
Microsoft
56693
MSFT
Amazon
51850
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Procter & Gamble
PG
Mkt Cap396.41B
Procter & Gamble competes with Haleon in the consumer health sector, offering a wide range of products in oral care, personal health care, and other categories.
Johnson & Johnson
JNJ
Mkt Cap372.29B
Johnson & Johnson operates in the pharmaceuticals, medical devices, and consumer health sectors, directly competing with Haleon's range of over-the-counter health products.
GSK
GSK
Mkt Cap81.55B
GlaxoSmithKline, the former parent company of Haleon, remains a competitor through its consumer healthcare products, despite the spin-off.
Pfizer
PFE
Mkt Cap169.83B
Pfizer has a consumer healthcare division that competes with Haleon in various health product categories.
Novartis
NVS
Mkt Cap232.42B
Novartis, through its Sandoz division, competes in the generic and over-the-counter medicine market, overlapping with Haleon's product range.
Sanofi
SNY
Mkt Cap128.21B
Sanofi operates in the consumer healthcare sector, offering products that compete across several of Haleon's key categories.
Merck &
MRK
Mkt Cap318.55B
Merck, known as MSD outside the United States and Canada, competes with Haleon through its range of health products and vaccines.
Abbvie
ABBV
Mkt Cap304.29B
AbbVie, through its broad range of pharmaceutical products, competes in areas that overlap with Haleon's consumer health portfolio.
Roche
RHHBY
Mkt Cap220.72B
Roche, with its focus on pharmaceuticals and diagnostics, competes indirectly with Haleon by offering alternative therapeutic and preventive health solutions.

About

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Show more...
CEO
Employees
25408
Country
GB
ISIN
GB00BMX86B70
WKN
000A3DNZQ

Listings

MX
MX
HLN.MX
F
DE
H6D0.F
MX
MX
HLN1.MX
XETRA
DE
H6D0.XETRA